Oxygen Therapeutics for Enhanced Industrial Processes

Publication ID: 24-11857627_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Oxygen Therapeutics for Enhanced Industrial Processes,” Published Technical Disclosure No. 24-11857627_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857627_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,627.

Summary of the Inventive Concept

The inventive concept leverages the core technology of oxygen therapeutics to improve outcomes in various industrial processes, including agriculture, oil recovery, wastewater treatment, aquaculture, and bioreactors.

Background and Problem Solved

The original patent addressed the limitation of hypoxia in solid tumors, but the technology has broader applications. The inventive concept solves the problem of oxygen deficiencies in various industrial processes, leading to improved efficiency, productivity, and environmental sustainability.

Detailed Description of the Inventive Concept

The inventive concept involves administering oxygen therapeutics in combination with precision agriculture practices to improve crop yields, enhancing oil recovery by increasing oxygen levels in reservoirs, treating wastewater by increasing oxygen levels, reducing the environmental impact of aquaculture by administering oxygen therapeutics to the aquatic environment, and improving the efficiency of bioreactors by increasing oxygen levels. These applications leverage the oxygen therapeutic's ability to increase oxygen levels, thereby improving process outcomes.

Novelty and Inventive Step

The new claims introduce novel applications and use cases for the oxygen therapeutic technology, expanding its scope beyond cancer treatment to various industrial processes. The inventive step lies in recognizing the broader potential of the technology and adapting it to address specific challenges in these new fields.

Alternative Embodiments and Variations

Alternative embodiments may include different oxygen therapeutic formulations, administration methods, or sensor technologies to optimize oxygen levels. Variations may also involve integrating the oxygen therapeutic with existing industrial processes or developing new processes that take advantage of the technology's benefits.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including agriculture, oil and gas, wastewater treatment, aquaculture, and biotechnology. The market for oxygen therapeutics in these industries is substantial, with potential applications in improving crop yields, enhancing oil recovery, reducing wastewater treatment costs, promoting sustainable aquaculture, and increasing bioreactor efficiency.

CPC Classifications

SectionClassGroup
A A61 A61K41/0038
A A61 A61K9/0019
A A61 A61K9/107
A A61 A61K31/02
A A61 A61K33/00
A A61 A61K39/395
A A61 A61K45/06
A A61 A61K47/10
A A61 A61K47/24
A A61 A61K47/26
A A61 A61N5/10
A A61 A61K2039/505
A A61 A61K2039/545
A A61 A61N2005/1098

Original Patent Information

Patent NumberUS 11,857,627
TitleFractionated radiotherapy and chemotherapy with an oxygen therapeutic
Assignee(s)NuvOx Pharma LLC